RAS Mutation: Being Precise in Precision Medicine

Time: 10:00 am
day: Day Two


• Clinical and translational perspective on previous clinical trial disappointments with RAS targeting

• Looking towards immunotherapy combinations with small molecules in the lung cancer landscape

• Examination of whole genome/exome sequencing results from RAS mutant lung cancer